Tuyo Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: shoppers wanting low-cost compounded glp-1 on an all-inclusive plan
Tuyo Health scores below our bar on medical oversight — read the score breakdown before signing up.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Tuyo Health (tuyohealth.com) is a US telehealth weight-loss program founded by Dr. German Echeverry that offers both compounded and brand-name GLP-1 medication. Compounded semaglutide starts at 155 dollars per month and compounded tirzepatide at 279 dollars per month, all-inclusive with custom protocol, free same-week shipping, complimentary medical consultations and periodic lab work. Brand-name Wegovy and Zepbound plans start around 399 to 499 dollars per month plus a 99 dollar membership, and can be lower with insurance. Support is by phone at 866-642-8054 and email.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Tuyo Health
Editorial score · methodology
Breeze Meds
Best for: compounded GLP-1 access with named prescribers and 4-pharmacy network
Editorial score · methodology
Telos Rx
Best for: Needle-free, microdosed compounded GLP-1 with lab-monitored care
Editorial score · methodology
Tuyo Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $155/mo (All-inclusive: protocol, consults, shipping and periodic labs)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- 1 FDA warning letter on record — see below
How we scored Tuyo Health
Each dimension is scored algorithmically from Tuyo Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.9/10At $155/mo, Tuyo Health runs about 8% below the $169 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.1/10Tuyo Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.4/10Online intake and platform experience — consult included in the price; 6 platform features disclosed.
Trust & Safety15%
5.3/10Core details confirmed by our editors; an FDA warning letter is on file (see flag above) (last checked 2026-08-02).
Accessibility10%
6.1/10Tuyo Health's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.9/10Tuyo Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Tuyo Health review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with Tuyo Health
We walked Tuyo Health’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Create an account.
- 2Answer medical-history questions for pre-approval.
- 3A board-certified provider evaluates you and, if appropriate, prescribes.
- 4Medication ships (free same-week shipping); dose is titrated over time.
- Compounded semaglutide starts at $155/month and compounded tirzepatide at $279/month, all-inclusive with no membership fee.
- Branded options (Wegovy, Zepbound) are available with a $99 membership fee and cash prices from $399-$499, or about $25/mo when insurance covers the medication.
- Plans include virtual consults, clinical support, and lab work (every 3 months for compounded, every 6 months for branded).
- The program is 100% online, no insurance needed for compounded plans, and HSA/FSA eligible.
- Compounded GLP-1s are disclosed as not FDA-approved.
- Stated eligibility: BMI 30+, or 27+ with a related condition, or transferring with a valid prescription.
Tuyo Health customer support
- Phone
- 866-642-8054
GLP-1 medications Tuyo Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
All-inclusive: protocol, consults, shipping and periodic labs
All-inclusive compounded plan; brand Zepbound also offered separately
Ready to get started?
Plans and promotions change often — check Tuyo Health's current pricing and active discounts before you decide.
What we like
- Low starting price of 155 dollars per month for compounded semaglutide, all-inclusive
- Offers both compounded and brand-name Wegovy and Zepbound, with an insurance option
- Free same-week shipping, complimentary consults and periodic lab work included
Watch-outs
- Service-area states not published
- No specific compounding pharmacy named on the site
- Brand-name plans add a separate 99 dollar membership fee
Is Tuyo Health worth it? Our verdict
Tuyo Health positions itself around one thing: shoppers wanting low-cost compounded glp-1 on an all-inclusive plan. It runs $155/month, flat across every dose. Its flat, all-dose pricing is a genuine plus for anyone worried about cost climbing as they titrate up.
What gives Tuyo Health its own flavor: Lab work.
How much Tuyo Health actually costs
- Compounded semaglutide — $155/month
- Compounded tirzepatide — $279/month
That's roughly in line with the ~$169/month median across the GLP-1 providers we track.
For a direct comparison, SkinnyRx runs semaglutide and tirzepatide from $149.25/month — worth pricing against Tuyo Health before you commit.
Medications: what Tuyo Health prescribes
Tuyo Health prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy — the reason the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Who Tuyo Health is best for — and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
- want a provider with a clean regulatory record — note the FDA warning flagged at the top of this page.
Trust, safety, and medical oversight
It does have an FDA warning letter on file, which we flag at the top of this review — read it before starting. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Tuyo Health is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding. One important caveat: it has an FDA warning letter on file — read it (flagged at the top of this review) and talk with a clinician before choosing it.
The Bottom Line
Tuyo Health scores below our bar on medical oversight — read the score breakdown before signing up.
Ready to start with Tuyo Health?
Starting at $155/month. See current pricing and start your free consultation.
Tuyo Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
Tuyo Health received an FDA warning letter dated September 9, 2025
The letter concerns unlawful sale of unapproved and misbranded drugs to united states consumers over the internet (telehealth). FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity — companies often respond with corrective action.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Tuyo Health review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Tuyo Health's current pricing
Plans start at $155/month. Start your free consultation to check eligibility and today's price.